The Chief Commercial Officer from the Department of Health and Social Care has written a letter with an update on plans and preparations ahead of the end of the Brexit transition period, regarding the continuity and uninterrupted supply of medicines and medical products such as:
- medicines and medical devices
- supplies for clinical trials and clinical investigations
- blood, tissue and transplant materials
- vaccines and countermeasures
The letter includes updates on border planning assumptions, alternative routes, shortage management response, useful links and more.